When was Sanity Group founded?

Sanity Group was founded in 2011 and raised its 1st funding round 8 years after it was founded.

Where is Sanity Group located?

Sanity Group is headquartered in Berlin, Germany.

Which legal entities is Sanity Group associated with?

Sanity Group is associated with Sanity Group GmbH and 1 other.

How many employees does Sanity Group have?

As of Mar 31, 2026, the latest employee count at Sanity Group is 111.

Is Sanity Group a funded company?

Sanity Group is a funded company, having raised a total of $109M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 08, 2019.

When was the latest funding round of Sanity Group?

Sanity Group's latest funding was a $***** Series B round on Sep 27, 2022, with participation from 15 investors.

Where does Sanity Group rank among its competitors?

Sanity Group ranks 1st amongst 228 active competitors, of which 24 are funded. It stands 1st in terms of total funding among its competitors.

Who are the top competitors of Sanity Group?

Sanity Group's top competitors include ZYUS Life Sciences, Avicanna and IMCannabis. Among them, Sanity Group secured the most recent funding round in September, 2022.

Sanity Group - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Sanity Group an acquired company?

Sanity Group got acquired by Organigram on Feb 18, 2026.

Sanity Group is an acquired company based in Berlin (Germany), founded in 2011 by Fabian Friede and Finn Age Hansel. It operates as a Developer of cannabinoid-based pharmaceuticals and well-being products. Sanity Group has raised $109M in funding from investors like HV Capital, British American Tobacco and Redalpine. The company has 228 active competitors, including 24 funded and 50 that have exited. Its top competitors include companies like ZYUS Life Sciences, Avicanna and IMCannabis.

Company Details

Developer of cannabinoid-based pharmaceuticals and well-being products The company develops pharmaceuticals and makes them accessible and available to pharmacists, physicians, and patients in Europe. It Also develops CBD and hemp-based products for wellbeing, relaxation, sleep aid, sports recovery gel. mouth spray for oral health and sanity Group is a developer of cannabinoid-based pharmaceuticals and well-being products.. hygiene, and CBD-based vaping pens.

Website: sanitygroup.com/en/home/
Social
Email ID: *****@sanitygroup.com
Phone Number: +49 **********

Key Metrics

Founded Year

2011

Location

Berlin, Germany

Stage

Acquired

Total Funding

$109M in 6 rounds

Latest Funding Round

Series B, Sep 27, 2022, $*****

Investors

HV Capital & 19 more

Ranked

1^st among 228 active competitors

Employee Count

111 as on Mar 31, 2026

Similar Companies

ZYUS Life Sciences & 267 more

Exit Details

Acquired by Organigram (Feb 18, 2026)

View Sanity Group's full profile

Sanity Group is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sanity Group GmbH CIN: HRB206368 , Germany, Active	Dec 31, 2010	-	10 (As on Dec 31, 2019)
Sanity Group GmbH CIN: F1103_HRB206368B , Germany, Active	May 03, 2019	-	-

Sanity Group got acquired by Organigram on Feb 18, 2026 at an acquisition amount of $134M.

Click here to take a look at Sanity Group's acquisition in detail

Sanity Group has raised a total funding of $109M over 6 rounds. Its first funding round was on May 08, 2019. Its latest funding round was a Series B round on Sep 27, 2022 for $*****. 15 investors participated in its latest round. Sanity Group has 15 institutional investors and 5 angel investors.

Here is the list of recent funding rounds of Sanity Group:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 27, 2022	9090649	Series B	9291594	5735182	4440829	7867774
Nov 03, 2021	5992660	Series A	5039092	3590373	7487998	Redalpine & 8 more
Jun 15, 2021	6202934	Series A	8862035	1733223	Redalpine & 1 more	German Media Pool & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Sanity Group's funding rounds and investors

The founders of Sanity Group are Fabian Friede and Finn Age Hansel.

Here are the details of Sanity Group's key team members:

Fabian Friede: Former Co-Founder of Sanity Group and founder of 1 other company.
Contact Info: 1 email address
Finn Age Hansel: Co-Founder & CEO of Sanity Group and founder of 1 other company.
Contact Info: 1 email address

View details of Sanity Group's Founder profiles and Board Members

Sanity Group's employee count trend

Sanity Group has 111 employees as of Mar 26. Here is Sanity Group's employee count trend over the years:

Uncover Sanity Group's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sanity Group include ZYUS Life Sciences, Avicanna and IMCannabis. Here is the list of Top 10 competitors of Sanity Group, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sanity Group 2011, Berlin (Germany), Acquired	Developer of cannabinoid-based pharmaceuticals and well-being products	$109M	HV Capital, SevenVentures & 18 others	67/100
2nd	ZYUS Life Sciences 2018, Saskatoon (Canada), Public	Developer of cannabis-derived therapeutics for multiple indications	$19.5M	Keyhorse Capital, Mammoth View	55/100
3rd	Avicanna 2016, Toronto (Canada), Public	Developer of plant-derived cannabinoid-based products	$5.94M	Orthogonal Thinker, Tasly & 1 others	51/100
4th	IMCannabis 2008, Herzliya (Israel), Public	Developer of medical cannabis products	-	-	49/100
5th	Grow Group 2017, London (United Kingdom), Series C	Developer of cannabis-based medicines for multiple indications	$12.6M	-	49/100
6th	Little Green Pharma 2016, Perth (Australia), Public	Manufacturer of medicinal cannabis for therapeutic use	$1.91M	Fastforward Innovations	46/100
7th	Oxford Cannabinoid Technologies 2017, Oxford (United Kingdom), Public	Developer of cannabinoid-based therapies	-	Casa Verde Capital, Kingsley Capital Partners	44/100
8th	Terraflos 2021, Uruguay, Seed	Provider of cannabis medical products	$8M	MPE Investment, YaaX Capital & 2 others	44/100
9th	Ananda Pharma 2018, London (United Kingdom), Public	Developer of cannabinoid-based medicines for chronic inflammatory conditions	-	-	44/100
10th	RAMM Pharma 1988, Montevideo (Uruguay), Public	Developer of cannabinoid pharmaceuticals	-	-	43/100